Brought to you by 
bioMerieux gets US rights to AdvanDx's PNA FISH test
04 Jun 2007
Executive Summary
AdvanDx (infectious disease diagnostics) has licensed bioMerieux exclusive US distribution rights to its PNA FISH (peptide nucleic acid fluorescence in situ hybridization) rapid diagnostics for bloodstream infections.
Deal Industry
- In Vitro Diagnostics
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
bioMerieux gets US rights to AdvanDx's PNA FISH test
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice